The Predictive Efficacy of Tumor Mutation Burden (TMB) on Nonsmall Cell Lung Cancer Treated by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

BACKGROUND: Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, and the majority of NSCLC patients are diagnosed at the advanced stage. Chemotherapy is still the main treatment at present, and the overall prognosis is poor. In recent years, immunotherapy has developed rapidly....

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Zhang, Guoqing, Wang, Xiaoxu, Yu, Yin, Mi, Xin, He, Xue, Li, Rong, Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984892/
https://www.ncbi.nlm.nih.gov/pubmed/33791360
http://dx.doi.org/10.1155/2021/1780860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984892/
https://www.ncbi.nlm.nih.gov/pubmed/33791360
http://dx.doi.org/10.1155/2021/1780860

Ejemplares similares